Literature DB >> 31135227

A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis.

Mallory J E Loflin1, Kimberly Babson2, James Sottile3, Sonya B Norman1,4, Staci Gruber5, Marcel O Bonn-Miller6.   

Abstract

Background: With a rise in public pressure to increase veteran access to medicinal cannabis, free cannabis collectives for military veterans are proliferating across the US.
Objectives: The aim of the current study was to document which cannabis formulations and routes of administration are chosen by veterans with increased access to cannabis, and to determine whether cannabis is being used as a substitute for other licit and illicit drugs. Method: The current study collected cross-sectional self-report data on cannabis use, cannabinoid constituent composition, primary indication of use, and substitution practices among a sample of 93 US military veterans (84.9% male) with access to free cannabis. Result: Most of the sample reported using cannabinoids as a substitute for either alcohol, tobacco, prescription medications, or illicit substances, reported that they use cannabis frequently (Modal frequency >4x/day, Modal quantity = 5 to 8 grams/week), and primarily select higher-risk cannabis formulations (i.e., high THC/low CBD, smoked). The majority of the sample reported that they use cannabis to self-treat multiple physical and mental health conditions/symptoms. Conclusions: Results of the current study suggest that military Veterans with reduced barriers to access cannabis could be making both helpful and harmful choices regarding their cannabis use. These findings suggest that more guidance on the selection of cannabis-based products in this population is warranted, particularly as barriers to medicinal cannabis access are reduced.

Entities:  

Keywords:  Cannabis; marijuana; medicinal cannabis; substitution; therapeutics; veterans

Year:  2019        PMID: 31135227     DOI: 10.1080/00952990.2019.1604722

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  2 in total

1.  The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder.

Authors:  Marcel O Bonn-Miller; Megan Brunstetter; Alex Simonian; Mallory J Loflin; Ryan Vandrey; Kimberly A Babson; Hal Wortzel
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-09

2.  The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial.

Authors:  Marcel O Bonn-Miller; Sue Sisley; Paula Riggs; Berra Yazar-Klosinski; Julie B Wang; Mallory J E Loflin; Benjamin Shechet; Colin Hennigan; Rebecca Matthews; Amy Emerson; Rick Doblin
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.